From Crisis to Coordination: How AI Transformed Public Health Policies during COVID-19

Commentary Open Access

From Crisis to Coordination: How AI Transformed Public Health Policies during COVID-19

Author Information
1
School of Architecture, Design and Planning, The University of Queensland, Brisbane, QLD 4067, Australia
2
School of Public Health, Southeast University, Nanjing 210009, China
*
Authors to whom correspondence should be addressed.

Received: 26 May 2025 Accepted: 08 September 2025 Published: 28 September 2025

Creative Commons

© 2025 The authors. This is an open access article under the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).

Views:317
Downloads:60
Rural Reg. Dev. 2025, 3(4), 10016; DOI: 10.70322/rrd.2025.10016
ABSTRACT: The COVID-19 pandemic showed the shortcomings of traditional policy-making procedures and highlighted serious flaws in international public health institutions. Artificial intelligence (AI) became a transformative force in response to the crisis’s urgency, allowing for data-driven, flexible, and better-coordinated public health measures. This viewpoint article examines how AI improved communication, accelerated vaccine development and distribution, enhanced decision-making, and optimized healthcare delivery during the COVID-19 pandemic. These advancements collectively contributed to significant changes in public health policy. Real-time analysis of large, complex datasets, ranging from case numbers and mobility patterns to hospital capacities and disinformation trends, was made possible by AI technologies including machine learning (ML) and natural language processing (NLP). Timely interventions like resource allocation, targeted lockdowns, and control of misinformation were made possible by this capability. AI also played a crucial role in forecasting infection trends, identifying vulnerable populations, and informing evidence-based decisions. AI-powered solutions further enhanced public involvement and cross-sector cooperation through chatbots and digital platforms delivering trustworthy health information. Additionally, AI-powered solutions enhanced public involvement and cross-sector cooperation, including the use of chatbots and digital platforms to provide trustworthy health information. AI sped up supply chain optimization and candidate screening in vaccine development, guaranteeing efficient, and quick delivery. However, ethical issues including bias, data privacy, and equity in healthcare access were also brought about by the integration of AI. This study emphasizes the need for open, inclusive, and morally sound AI governance by highlighting AI’s twin roles as a technological enabler and a tool for policy. The pandemic provides a fundamental lesson for countries preparing for future health emergencies: AI may be a key instrument in creating public health systems that are more robust, responsive, and equitable if it is applied properly.
Keywords: Artificial intelligence; AI; COVID-19; Public health policy; Predictive analytics; Health communication; Vaccine distribution; Ethical challenges

1. Introduction

The COVID-19 pandemic was an unprecedented global crisis that demanded rapid and coordinated responses from governments, health organizations, and public institutions. Governments were under tremendous pressure to make prompt, data-driven choices as the virus spread across the world. These decisions were crucial to safeguarding public health, managing scarce resources, and aiding in economic recovery. It was soon discovered that traditional policy-making techniques, which mostly relied on manual data processing and delayed feedback loops, were insufficient. In this regard, AI became a game-changing instrument that revolutionized the development, application, and real-time modification of public health policy [1]. The COVID-19 pandemic spurred the use of AI in public health, providing fresh approaches to managing crisis communication, maximizing healthcare delivery, and tracking the spread of disease [2]. In a short time, AI emerged as a crucial element in guiding nations’ reactions to COVID-19, from predictive analytics to machine learning algorithms. AI’s incorporation into public health decision-making was a paradigm shift that went beyond merely increasing efficiency; it made it possible for real-time surveillance, dynamic resource allocation, and quicker assessment of the efficacy of interventions. Because of its capacity to handle enormous volumes of diverse data, from mobility patterns to epidemiological statistics, timely and useful intelligence could be used to inform policy decisions. Throughout the pandemic, AI applications cut across several tiers of public health governance. By predicting hospital capacity requirements and infection trajectories, predictive modelling methods allowed for proactive planning as opposed to reactive planning. Algorithms using natural language processing scanned social media for new patterns in disinformation, directing focused public relations campaigns. AI-driven diagnostic tools expedited testing capabilities, while computer vision systems helped monitor crowd density or mask compliance. AI-powered contact tracing assisted in limiting infections before they reached catastrophic levels in countries like South Korea. AI’s contribution to promoting cross-border and interagency coordination was equally important. Due to the pandemic’s rapidity and scope, local, national, and worldwide health organizations had to share information in a way never seen before. AI tools made it easier to standardize data formats, identify irregularities in various reporting systems, and combine results into a single dashboard that decision-makers could view. In situations where disjointed health systems could have normally prevented coordinated response, this digital coordination infrastructure proved particularly crucial. This study briefly looks at how AI changed the mindset of public health governance during a crisis, pushing it toward agility, openness, and evidence-based adaptation, in addition to enabling more effective responses. The conversation will highlight the revolutionary achievements as well as the ethical challenges that surfaced through an examination of case studies and important AI functions. In the end, the insights gleaned from COVID-19’s AI-powered reactions could influence how societies get ready for and handle upcoming international health crises. This study also seeks to close the gap between institutional preparation and technological competence by placing these advancements in a larger policy and governance framework. The quick expansion of AI tools during COVID-19 demonstrated the value of public trust, cross-sector cooperation, and regulatory adaptability in addition to the capacity for innovation under duress. It is evident from considering the lessons learnt that incorporating AI into public health policy cannot be handled as a stand-alone emergency remedy; rather, it needs to be incorporated into long-term preparedness plans. This would guarantee that governments will begin from a position of coordinated, data-driven resilience rather than reactive improvisation when the next crisis, whether it will be a pandemic, environmental disaster, or other large-scale threat occurs.

2. The Role of AI in Data-Driven Decision Making

The vast volume of data produced by multiple sources—global case counts, health outcomes, testing rates, hospital capabilities, and economic indicators—was immense. Managing this data was one of the largest obstacles during the COVID-19 crisis [3]. It was difficult for governments and healthcare institutions to compile this enormous amount of data and derive useful insights instantly. Hence, AI was essential in turning unstructured data into insightful knowledge that might guide policy choices. Faster and more accurate data analysis was made possible by AI-powered algorithms, especially those that used Machine Learning (ML) and Natural Language Processing (NLP) [4]. For instance, by examining patterns in real-time case reports, demographic trends, migration patterns, and historical data, ML models assisted in forecasting the course of the virus’s transmission. The ability of governments and health organizations to predict possible hot spots allowed for more focused actions, such as travel bans, lockdowns, and the distribution of medical resources. AI was instrumental in tracing contacts and pinpointing infected case clusters in nations like South Korea, helping to slow transmission before outbreaks reached dangerous proportions [5]. AI was used not only to track illnesses but also to predict the needs of the health system and avoid service outages. Future demand for intensive care units (ICUs), ventilators, and staffing shortages was projected by predictive algorithms. AI could give early warnings when certain facilities were likely to be overloaded by combining past hospital performance data with current patient intake statistics. These systems aided in prioritizing resource distribution and coordinating inter-hospital transfers during the early phases of the pandemic, when hospitals had to deal with an unexpected surge of patients and challenging triage decisions. One noteworthy instance of AI-assisted decision-making was provided by the National Health Service (NHS) in the United Kingdom. In order to predict hospital demands at the regional level, AI models combined daily admissions, bed occupancy, and mortality rates. Both the establishment of temporary “Nightingale” hospitals and the nationwide stockpile deployments were influenced by these projections. Similar to this, the US Department of Health and Human Services collaborated with tech companies to create predictive dashboards that combined hospital capacity metrics, mobility data, and COVID-19 case trends. This allowed governors and local health departments to make more rapid, evidence-based policy changes. AI’s influence extends to social and economic policy issues. Policymakers had to balance the economic effects of public health measures during the pandemic. Governments were able to estimate the trade-offs between more stringent lockdowns and economic activity because to AI models that could combine epidemiological projections with job statistics, consumer spending trends, and supply chain disruptions. Phased reopening tactics were informed by these simulations, which made it possible to implement more precise actions as opposed to imposing severe, universally applicable limitations. Another useful application of natural language processing was the synthesis of the vast amount of scientific material that was being produced every day. NLP was used by tools such as the Allen Institute for AI’s “COVID-19 Open Research Dataset” (CORD-19) to assist academics and policymakers in discovering pertinent results in tens of thousands of studies. This sped up the process of turning new data into policy, especially for developing subjects like mask effectiveness, airborne transmission, and vaccine trial outcomes. A move toward real-time governance was also encouraged by the incorporation of AI into decision-making procedures. Public health policy has historically relied on weekly or monthly reporting cycles and retrospective analysis. Decision-makers might keep an eye on hourly-updated dashboards with AI-enabled tools, enabling them to spot early warning signs and make necessary adjustments before things got worse. This change was especially noticeable in nations like Taiwan and New Zealand, where quick, data-driven changes helped containment plans in the early stages of the pandemic/epidemic be comparatively effective. For policymakers, AI essentially served as both a microscope and a telescope, offering detailed insights into current issues while simultaneously forecasting potential outcomes. The ability to combine disparate datasets—from mobility patterns to hospital admissions—into comprehensible and useful knowledge marked a paradigm shift in public health decision-making. One of COVID-19’s most lasting effects on health policy may be this move toward predictive, adaptive governance.

3. Enhancing Public Health Communication and Coordination

During the COVID-19 pandemic, AI was crucial in enhancing public health coordination and communication in addition to being a tool for data analysis and resource allocation [6]. One of the key challenges governments faced during the COVID-19 pandemic was ensuring that accurate, up-to-date information reached the public in a timely and comprehensible manner. As fear and false information spread, especially on social media, this became increasingly difficult to manage. Governments and health organizations have employed AI-driven systems to track and evaluate the dissemination of incorrect information in real time in an effort to counteract misinformation [7]. Automated systems and bots with AI capabilities were utilized to identify false claims, point consumers to trustworthy sources, and even engage with the public to allay concerns. International organizations and health ministries have also implemented AI chatbots to respond to frequently asked inquiries and offer advice on symptoms, testing sites, and preventive actions. The World Health Organization (WHO), for instance, unveiled a COVID-19 chatbot that offered evidence-based information in several languages [8], including up-to-date information on the number of cases worldwide. By offering a common platform for data access and decision-making, AI promoted cross-agency cooperation in terms of policy coordination. AI systems combined data from hospitals, research centers, and public health organizations to produce a more comprehensive picture of the pandemic’s effects. This coordinated strategy made responses more efficient and guaranteed that choices were founded on the most up-to-date and thorough information available. AI-enabled technologies were also used to track the distribution of vaccines and medical supplies. This helped ensure that resources were allocated fairly and effectively across regions.

4. AI in Vaccine Development and Distribution

The creation and dissemination of vaccinations was one of AI’s most significant contributions during the COVID-19 pandemic [9]. Capacity of AI to model protein structures and interpret intricate biological data sped up the vaccine development process, cutting down on the usual time frame for vaccine synthesis. By modelling how various substances would interact with the virus’s spike protein, AI systems were used to find prospective vaccine candidates [10]. This method sped up clinical trials and regulatory approval procedures by enabling scientists to quickly identify the best solutions. The typical vaccine development timetable was significantly cut by AI’s capacity to model protein structures, analyze intricate biological datasets, and quickly simulate therapeutic interactions. Due in part to AI-driven computational biology, the urgent worldwide demand accelerated the vaccine development process, which would have otherwise taken years. Therefore, AI was essential to vaccine distribution in addition to speeding up vaccine research [11]. AI-based solutions were used to optimize supply chain management, one of the most difficult parts of the worldwide vaccination deployment. These technologies helped guarantee that vaccines were effectively delivered to the areas most in need, tracked manufacturing rates, and kept an eye on the storage needs for vaccines. Governments were able to proactively manage possible delays in vaccination delivery by using AI techniques to forecast logistical obstacles [12]. Furthermore, AI played an effective role in the deployment of digital vaccination certificates, which were essential for foreign travel and economic recovery. The use of AI-powered technologies to confirm the legitimacy of digital health records allowed for smooth travel and movement of individuals. It also reduced the possibility of fake vaccination certificates. In the following parts of this section, we delve into details of each phase and relevant descriptions of AI contributions. These also include specific examples of AI platforms or tools used by governments or health systems. During the research phase, scientists were able to model the SARS-CoV-2 spike protein with amazing accuracy because to AI-powered technologies like DeepMind’s AlphaFold, which revolutionized protein structure prediction. The development of vaccinations that might trigger a specific immune response was aided by this structural understanding, which was essential in determining how the virus attaches to human cells. Similar to this, Benevolent AI’s platforms and IBM’s Watson for Drug Discovery gathered extensive clinical data and biomedical literature to recommend possible adjuvant combinations and antigen targets. By simulating millions of potential chemical interactions in silico, these systems could reduce the number of promising candidates for testing in the lab. Additionally, immune response heterogeneity across various demographic groups was predicted by machine learning (ML) models. For instance, BioNTech optimized the design of its mRNA vaccine by choosing sequences with the best projected stability and immunogenicity using AI-enhanced algorithms. Faster iterations and a more seamless transfer from pre-clinical research to clinical trials were made possible by such modelling. AI also influenced vaccine adaption to new variations by combining virological analysis with real-world epidemiological data. Near-real-time genomic surveillance was made possible by tools like Nextstrain, which tracks viral development using machine learning. As variants like Delta and Omicron spread quickly, this made it possible for vaccine developers to predict spike protein alterations and take into account modifying vaccine formulations. Beyond discovery, AI played a key role in the dissemination of vaccines, posing an unprecedented logistical challenge. The management of manufacturing rates, cold-chain storage needs, delivery routes, and equitable allocation across locations with widely disparate infrastructural capacities was a task for governments and health groups. AI-based or AI-driven supply chain optimization tools, such Microsoft’s Vaccine Management Solutions and Blue Yonder Luminate Control Tower, integrated real-time data from delivery fleets, production facilities, and distribution centers. Predictive analytics was employed by these systems to anticipate bottlenecks, suggest rerouting in the event of transportation delays, and adjust allocations in accordance with shifting regional demand. In the United States, for instance, the Department of Health and Human Services collaborated with Palantir’s Tiberius platform to integrate supply chain, epidemiological, and demographic data, allowing state-level decision-makers to distribute doses according to both necessity and practicality. Another area where AI had a noticeable impact was cold-chain monitoring. Ultra-low storage temperatures were necessary for Pfizer’s mRNA vaccine, and deviations could jeopardize dosage integrity. Real-time temperature conditions were tracked by AI-powered IoT sensors and analytics platforms, which warned operators of any irregularities and recommended remedial measures. AI-enabled cold-chain management decreased waste rates and made ensuring vaccinations arrived in viable condition in nations like Canada and Germany. Additionally, forecasting models assisted governments in scheduling community outreach programs, predicting uptake rates, and anticipating staffing requirements at vaccination clinics. For instance, India managed appointment scheduling, eased congestion at distribution stations, and guaranteed fair access in rural areas by utilizing AI algorithms in the CoWIN platform. In here, we also summarise key aspects related to AI in verification and enhancing public confidence. Assuring the validity and compatibility of immunization records was another layer of policy. AI-powered verification techniques were used to confirm digital health passes when vaccination certificates become a requirement for travel abroad and for reopening economies. By using AI algorithms to compare QR codes to secure databases, the European Union’s EU Digital COVID Certificate Gateway decreased the possibility of fake papers. Similar to this, AI-enhanced verification systems in Singapore allowed for easier travel while preserving border biosecurity by instantly comparing immunization records with immigration and health databases. AI also had an impact on vaccination programs in the field of public communication. Chatbots driven by natural language processing systems, such the WHO’s Health Alert on WhatsApp and India’s MyGov Corona Helpdesk, were able to refute false material, provide advice on scheduling appointments, and respond to questions about vaccines in a variety of languages. These AI technologies assisted in combating vaccination reluctance stoked by internet disinformation by automating reliable, approachable communication.

Integrating Clinical and Policy Layers for Greater Impact

The merging of AI’s clinical/scientific and policy/logistical applications produced a feedback loop that improved overall efficiency, despite their distinct purposes. For example, AI-driven genomic surveillance of variations influenced logistical choices, such where to focus booster programs, in addition to vaccine redesign. Similar to this, data from supply chain optimization is sent back into policy dashboards, allowing for real-time national and subnational vaccination strategy modifications. The transformation of vaccine innovation into public health results was made possible by this two-layered paradigm, which combines AI for scientific acceleration with AI for policy execution. The former might have been severely weakened in the absence of the latter due to distribution bottlenecks, unfair distribution, or deteriorations in public confidence. The COVID-19 pandemic highlights that the effectiveness of AI in responding to global health crises depends not only on its ability to produce answers but also on the mechanisms in place to distribute those solutions fairly and effectively. When the next global health emergency strikes, integrating these AI capabilities into long-term pandemic preparedness strategies may guarantee that vaccine development and distribution are quicker, more equitable, and more resilient. AI’s ability to expedite vaccine development and plan worldwide distribution was not just a technical achievement; rather, it was an example of what can be achieved when science, policy, and digital innovation work together. Long-held beliefs about the scope and speed of public health action were upended by the speed at which AI converted genomic data into effective vaccinations and then coordinated their distribution to billions. However, this accomplishment also established a new standard by which future crises will be evaluated in relation to this degree of quickness and integration. Whether or not countries can institutionalize these capabilities and integrate them into health systems as long-term foundations of readiness, equity, and trust—rather than as emergency tools—will be the true test of COVID-19’s AI legacy. Anything less runs the risk of wasting one of the biggest advancements in public health capabilities in contemporary history.

5. Challenges and Ethical Considerations

Aside from its noteworthy benefits, the application of AI to COVID-19 public health policy also brought up substantial obstacles and moral dilemmas [13,14]. The reliance on AI algorithms for critical decisions exposed the potential for bias and inequality. This was particularly evident in areas such as resource allocation and predictive modelling.AI can unintentionally perpetuate past imbalances or gaps in healthcare access if the underlying data used to build AI models was skewed [15]. For instance, predictive models that did not account for the social determinants of health may have underrepresented vulnerable populations, leading to unequal access to care and resources. The security and privacy of health data were additional issues. Concerns regarding the collection and storage of private health data were highlighted by the growing use of AI to track and monitor the pandemic. Although they were successful in stopping the virus’s spread, AI-driven contact tracing and quarantine enforcement technologies also sparked discussions about data privacy. They also raised concerns about the possibility of overreaching surveillance. Complex ethical challenges resulted from governments and health organizations having to strike a balance between the necessity of public health surveillance and people’s right to privacy. During the pandemic, the rapid adoption of AI-powered technologies also raised awareness of privacy and surveillance issues. India’s Aarogya Setu mobile application, which was introduced in April 2020 as a component of the nation’s pandemic containment strategy, was one of the most talked-about examples [16]. In order to identify hotspots, detect possible COVID-19 exposures, and direct users toward testing and quarantine procedures, the app made use of GPS and Bluetooth technology. Aarogya Setu received praise for its rapid detection of infection clusters and its ability to trace contacts on a never-before-seen scale [17], but it was also criticized for its opaque data governance procedures. Similar to this, wearable tokens and the TraceTogether app in Singapore were first hailed for their effectiveness in contact tracing before coming under fire after it was discovered that law enforcement might use the data gathered for criminal investigations [18]. The conflict between public trust and the state’s wider security capabilities was brought to light by this revelation, which was made months after the technology’s debut [19]. It also reaffirmed calls for clear legal protections to restrict the use of public health data. 5.1. Balancing Public Health Necessity and Civil Liberties Asia was not the only region to experience the moral conflict between the need for public health monitoring and the defense of individual liberties. Decentralized versus centralized data architectures for contact tracing applications were hotly debated throughout Europe. Due to public outcry and pressure from privacy experts, Germany made the early decision to switch from a centralized paradigm to a decentralized, privacy-preserving structure that was in line with the Apple/Google Exposure Notification API [20]. Some epidemiological insights that health authorities could have gained from more thorough, consolidated data were also restricted by this move, even though it may have decreased the risk of surveillance. The fundamental governance dilemma is exemplified by this trade-off: while real-time, detailed data is crucial for handling public health emergencies, its gathering and application must be balanced against possible misuse, long-term effects on civil liberties, and the deterioration of public confidence. Even the most advanced AI systems may be undermined once public health policies are no longer trusted. Beyond ethical, there were major logistical challenges in using AI. The efficacy of AI-powered health interventions was restricted in many low- and middle-income nations by a lack of digital infrastructure and inconsistent internet connectivity. Even in countries with robust digital ecosystems, interoperability between different data systems proved challenging. For instance, hospital data, primary care records, and public health databases were all kept in disparate formats and subject to disparate data-sharing agreements, which originally caused difficulties for the UK’s NHS AI tools for COVID-19 risk prediction [21]. This fragmented environment hindered AI models’ ability to offer real-time, actionable insights and impeded their incorporation into normal decision-making. Ensuring widespread adoption in a society with significant socioeconomic and linguistic variety was a distinct operational challenge for India’s Aarogya Setu. Although the app had over 100 million downloads in a matter of weeks, acceptance differed between rural and urban areas, partly because of disparities in smartphone penetration and partly because of skepticism over government technology. Such technologies, according to critics, run the risk of excluding the very groups most susceptible to the virus in the absence of robust community engagement. 5.2. Bias in Predictive Modelling and Resource Allocation The pandemic also highlighted the potential for bias in AI models to show up in choices about how to allocate resources. People from marginalized communities, who already faced higher rates of chronic illness due to social and economic determinants of health, were disproportionately affected by ventilator distribution algorithms implemented in some U.S. states. These algorithms were criticized for assigning lower priority scores to individuals with pre-existing health conditions. These examples highlight the necessity of conducting thorough fairness audits on AI systems before to implementation. In a fairness audit, model results are methodically checked for bias across demographic groups, and algorithms or input data are modified as necessary. However, these precautions were frequently neglected or applied too late during the midst of a public health emergency. Several paradigms for ethical AI governance in public health have been put out in an effort to address these issues. Transparency, accountability, inclusion, and proportionality have all been urged by the World Health Organization (WHO) as guiding principles [22]. Making AI models comprehensible and their reasoning open to public examination are essential components of transparency. Accountability guarantees distinct lines of accountability for AI-informed judgments. Diverse communities must be represented in datasets and policymaking processes to be inclusive. To be considered proportionate, the level of data collection and surveillance must be commensurate with the gravity and extent of the public health issue. When these guidelines are applied retroactively to the COVID-19 response, it becomes clear where AI deployment worked and where it didn’t. Iterative enhancements to NHS predictive technologies in the UK showed receptivity to expert and public input, advancing higher accuracy and fairness. Aarogya Setu’s data use rules in India were later made more transparent, including by open-sourcing some of the app’s code, because of public demand and activism. However, both instances also demonstrate how early decisions on governance and design can have a long-lasting effect on moral standards and public confidence. 5.3. Limitations and Contextual Constraints of AI in Pandemic Public Health Policy Even while AI’s revolutionary role in controlling the COVID-19 pandemic is widely known, it is as critical to recognize the limits of its potential and the environmental factors that influenced its actual performance. These restrictions are not only technical; they stem from a complicated interaction between public perception, governance preparedness, equity concerns, and data quality. The reliance of AI systems on the timeliness, accuracy, and availability of underlying data was one of the most significant constraints. For instance, in the early phases of the pandemic, machine learning models for infection predictions sometimes had trouble because of underreporting, irregular testing rates, and delays in local jurisdictions’ data submission [23]. Predictions were less reliable for policy action in nations with weak disease surveillance systems because they were prone to inaccuracy. Even in high-income settings, the potential influence of multiple datasets was reduced due to the inability of health organizations to integrate them into coherent AI models due to the lack of common data formats. The scalability and adaptability of AI technologies presented another challenge. Because of variations in demographics, cultural customs, and the structure of healthcare systems, models that were calibrated for one population or location did not necessarily translate well to another. For example, in rural or informal settlement situations, where social interactions and movement patterns varied significantly, algorithms trained on urban mobility data in high-income nations frequently failed to effectively simulate virus propagation. This brought to light the ongoing issue of “context transferability” in AI, which occurs when models that are optimized for one set of circumstances lose accuracy when used in another. Adoption was also hampered by interpretability concerns. Many AI systems, especially those that used deep learning, operated as “black boxes” with decision-making processes that were unknown to the general public and politicians [24]. Lack of explainability slowed uptake and diminished trust in life-or-death decisions, such vaccination prioritizing or ICU bed allocation, even when prediction accuracy was high [25]. Some governments restricted the use of increasingly complex but less interpretable models by requiring explainable AI results before incorporating them into operational decision-making. These technical limitations were exacerbated by social and ethical constraints. The data that AI systems are trained on naturally shapes them, and when that data reflects historical injustices, such as those related to racial representation, socioeconomic position, or healthcare access, those injustices may be replicated or even made worse. Systemic biases already prevalent in healthcare delivery were echoed by resource allocation algorithms in several jurisdictions during COVID-19, which ran the danger of deprioritizing vulnerable groups with pre-existing health issues. Continuous auditing is necessary to mitigate such biases, however fairness evaluations were frequently shortened or ignored completely due to the urgency of the pandemic response. Countries also differed greatly in their infrastructure readiness. While some nations used AI via integrating health data systems, others did not have the human resources, cloud computing access, or broadband coverage necessary to implement sophisticated analytics. These shortcomings made it impossible for AI tools created internationally to be used locally without considerable modification in low- and middle-income contexts, thus deepening the technology divide. Even in cases where technology was available, there were still extra challenges related to scale, maintenance, and cybersecurity protections. The efficacy of AI was found to be both influenced by and constrained by public trust. There were valid worries about privacy, surveillance, and data misuse as AI-driven contact tracing, symptom-checking applications, and vaccine certification systems were quickly implemented [26]. In certain nations, where only a small portion of the populace downloaded official tracing programs, public opposition lowered adoption rates below the levels required for the tools to be successful. This was made worse when governments failed to provide explicit protections or when legislative revisions later contradicted earlier promises about data use, as was the case in Singapore’s TraceTogether case. Lastly, there was a risk associated with operational reliance on AI. Without enough human oversight, an over-reliance on algorithmic projections ran the risk of limiting decision-making to what the model could predict, so ignoring qualitative, community-based intelligence. Models based on historical or early-phase data may soon become out of date in rapidly changing crises like COVID-19 when new varieties appear or public attitudes change. AI systems may unintentionally inform policy based on outdated or insufficient data if they are not regularly retrained and recalibrated. In sum, the limitations of AI during the pandemic highlight the fact that technological prowess by itself cannot ensure influence [27]. Meaningful and ethical use requires infrastructural preparedness, interpretability, public trust, equality protections, and data reliability. By acknowledging these limitations, AI is framed realistically—as a tool whose efficacy is contingent upon the social, political, and technological systems into which it is integrated—rather than having its contribution minimized. Coordinated investment in data governance, inclusive design, explainability standards, and community engagement will be necessary to address these constraints prior to the next global health emergency. This will guarantee that AI supports fair and reliable public health policy rather than creating new vulnerabilities.

6. The Future of AI in Public Health

The COVID-19 pandemic highlights the fact that AI in public health is a highly social and political issue rather than just a technological one. Future health emergencies will unavoidably present logistical and ethical difficulties, ranging from prejudice and unfairness to privacy issues and infrastructure deficiencies. Before the next pandemic strikes, the lessons learned from practical implementations—like Aarogya Setu and NHS AI tools—indicate the necessity of pre-emptive ethical preparation, strong public participation, and legal protections. Without these safeguards, the same life-saving technologies run the risk of eroding the same equality and public confidence they are meant to preserve. These facts demonstrate that the robustness of the ecosystems in which AI functions will be more important for its success in future crises than the innovation of its algorithms. Strong data governance, ongoing model validation, workforce training, and transparent public communication tactics that foresee issues before they become obstacles are all necessary for sustainable AI integration [28]. AI must be viewed by governments and institutions as an integrated part of robust health systems [29], tested in peacetime, improved through multi-sector collaboration, and implemented with openness and inclusivity at its heart, rather than as a short-term technology add-on for emergency usage. As the COVID-19 pandemic has demonstrated, AI has the ability to revolutionize public health policy [30]. The lessons acquired from AI’s engagement in COVID-19 will surely impact how AI is incorporated into public health policies as the world recovers from the pandemic and gets ready for future health emergencies. Recognizing the importance of data-driven decision-making in medical emergencies, governments and organizations are investing more in AI infrastructure. Interest in creating more robust health systems has increased because of the pandemic, and AI will become even more important in tracking, forecasting, and controlling future outbreaks. AI is a vital tool for anticipating and reducing future health risks because of its quick analysis of global health data, ability to monitor new diseases, and capacity to estimate the effects of actions. To sum up, AI allowed governments to make better, faster judgments on everything from data analysis and predictive modelling to resource allocation and vaccination distribution. Its ability to enhance public health policy coordination offers a glimpse of a future where data and technology work hand in hand to safeguard global health. However, significant obstacles remain, particularly in the areas of ethics and equity. Turning short-term success into long-term resilience will require institutionalizing AI capabilities, making investments in equitable access, fortifying governance frameworks, and maintaining public trust in order to sustain this development.

Statement of the Use of Generative AI and AI-Assisted Technologies in the Writing Process

During the preparation of this manuscript, the authors used embedded AI in Grammerly to assist with language editing and grammar refinement. All content was subsequently reviewed, revised, and approved by the authors, who take full responsibility for the final version of the manuscript.

Author Contributions

Conceptualization, A.C. and Z.S.; Methodology, A.C.; Validation, A.C., and Z.S.; Formal Analysis, A.C.; Investigation, A.C. and Z.S.; Data Curation, A.C.; Writing—Original Draft Preparation, A.C. and Z.S.; Writing—Review & Editing, A.C. and Z.S.; Project Administration, A.C.

Ethics Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Any data that may have been used in this article is publicly available.

Funding

This research received no external funding.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

1.
Betz UA, Arora L, Assal RA, Azevedo H, Baldwin J, Becker MS, et al. Game changers in science and technology-now and beyond. Technol. Forecast. Soc. Chang. 2023, 193, 122588. [Google Scholar]
2.
Alam F, Almaghthawi A, Katib I, Albeshri A, Mehmood R. IResponse: An AI and IoT-enabled framework for autonomous COVID-19 pandemic management. Sustainability 2021, 13, 3797. [Google Scholar]
3.
Khan JR, Awan N, Islam MM, Muurlink O. Healthcare capacity, health expenditure, and civil society as predictors of COVID-19 case fatalities: a global analysis. Front. Public Health 2020, 8, 347. [Google Scholar]
4.
Kalusivalingam AK, Sharma A, Patel N, Singh V. Enhancing Diagnostic Accuracy with AI-Powered Symptom Checkers: A Comparative Analysis of Natural Language Processing and Decision Tree Algorithms. Int. J. AI ML 2013, 2. Available online: https://cognitivecomputingjournal.com/index.php/IJAIML-V1/article/view/119 (accessed on 18 June 2024). [Google Scholar]
5.
Lee H, Kim Y, Kim E, Lee S. Risk assessment of importation and local transmission of COVID-19 in South Korea: Statistical modeling approach. JMIR Public Health Surveill. 2021, 7, e26784. [Google Scholar]
6.
Jabarulla MY, Lee HN. A blockchain and artificial intelligence-based, patient-centric healthcare system for combating the COVID-19 pandemic: Opportunities and applications. Healthcare 2021, 9, 1019. [Google Scholar]
7.
Onayinka TS, Opele JK, Adewole LB, Agbasimelo CI. Ethical implications and policy frameworks for ai-driven solutions to combat misinformation in digital media. UNIZIK J. Educ. Res. Policy Stud. 2024, 17. https://unijerps.org/index.php/unijerps/article/view/829 [Google Scholar]
8.
Amiri P, Karahanna E. Chatbot use cases in the COVID-19 public health response. J. Am. Med. Inform. Assoc. 2022, 29, 1000–1010. [Google Scholar]
9.
Piccialli F, Di Cola VS, Giampaolo F, Cuomo S. The role of artificial intelligence in fighting the COVID-19 pandemic. Inf. Syst. Front. 2021, 23, 1467–1497. [Google Scholar]
10.
Bagabir SA, Ibrahim NK, Bagabir HA, Ateeq RH. COVID-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery. J. Infect. Public Health 2022, 15, 289–296. [Google Scholar]
11.
Keshavarzi Arshadi A, Webb J, Salem M, Cruz E, Calad-Thomson S, Ghadirian N, et al. Artificial intelligence for COVID-19 drug discovery and vaccine development. Front. Artif. Intell. 2020, 3, 65. [Google Scholar]
12.
Addy A. Vaccine production and distribution challenges: an AI-assisted technologies for the overcoming of logistical hurdles faced by Sub-Saharan Africa with focus on Ghana. Vaccine 2024, 113, 33–47. [Google Scholar]
13.
Cheshmehzangi A, Su Z, Zou T. ICT applications and the COVID-19 pandemic: Impacts on the individual’s digital data, digital privacy, and data protection. Front. Hum. Dyn. 2023, 5, 971504. [Google Scholar]
14.
Anshari M, Hamdan M, Ahmad N, Ali E, Haidi H. COVID-19, artificial intelligence, ethical challenges and policy implications. AI Soc. 2023, 38, 707–720. [Google Scholar]
15.
Su Z, Cheshmehzangi A, Bentley BL, McDonnell D, Šegalo S, Ahmad J, et al. Technology-based interventions for health challenges older women face amid COVID-19: a systematic review protocol. Syst. Rev. 2022, 11, 271. [Google Scholar]
16.
Jhunjhunwala A. Role of telecom network to manage COVID-19 in India: Aarogya Setu. Trans. Indian Natl. Acad. Eng. 2020, 5, 157–161. [Google Scholar]
17.
Puri R. A Review of the Aarogya Setu Digital Contact Tracing Mobile Application of the Government of India in Response to the Novel Corona Virus [COVID-19]: A Local and International Perspective. 2020. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3744752 (accessed on 18 June 2024).
18.
Lee T, Lee H. Bodily surveillance: Singapore’s COVID-19 app and technological opportunism. Continuum 2023, 37, 621–634. [Google Scholar]
19.
Hansen MM, Dahiya B. TraceTogether contact tracing: a Smart Nation innovation. Front. Sustain. Cities 2025, 7, 1552449. [Google Scholar]
20.
Zuboff S. Surveillance capitalism or democracy? The death match of institutional orders and the politics of knowledge in our information civilization. Organ. Theory 2022, 3, 26317877221129290. [Google Scholar]
21.
Zhang J, Ashrafian H, Delaney B, Darzi A. Impact of primary to secondary care data sharing on care quality in NHS England hospitals. NPJ Digital Medicine 2023, 6, 144. [Google Scholar]
22.
Bouzarjomehri H, Maleki M, Masoudi-Asl I, Ranjbar M. Enhancing Transparency: Core Principles for a Developing Health System. World Med. Health Policy 2025, 17, 616–625. [Google Scholar]
23.
Ekundayo F. Using machine learning to predict disease outbreaks and enhance public health surveillance. World J. Adv. Res. Rev. 2024, 24, 794–811. [Google Scholar]
24.
Sudmann A. On the media-political dimension of artificial intelligence: Deep learning as a black box and OpenAI. Digit. Cult. Soc. 2018, 4, 181–200. [Google Scholar]
25.
Bhaskar AV. The Role of Artificial Intelligence and Machine Learning in Enhancing Decision-Making in Critical Care Units. Front. Health Inform. 2024, 13, 2601. [Google Scholar]
26.
Abbasi S, Jung BK. White Paper-Overview and Insight: Performance of Digital Health Systems During the COVID-19 Pandemic. Overview and Insight: Performance of Digital Health Systems During the COVID-19 Pandemic 2023; pp. 1–97. Available online: https://ieeexplore.ieee.org/abstract/document/10026272 (accessed on 18 June 2024).
27.
Agarwal S, Punn NS, Sonbhadra SK, Tanveer M, Nagabhushan P, Pandian KK, et al. Unleashing the power of disruptive and emerging technologies amid COVID-19: A detailed review. arXiv 2020, arXiv:2005.11507. [Google Scholar]
28.
Gupta P, Parmar DS. Sustainable Data Management and Governance Using AI. World J. Adv. Eng. Technol. Sci. 2024, 13, 264–74. [Google Scholar]
29.
Panteli D, Adib K, Buttigieg S, Goiana-da-Silva F, Ladewig K, Azzopardi-Muscat N, et al. Artificial intelligence in public health: promises, challenges, and an agenda for policy makers and public health institutions. Lancet Public Health 2025, 10, e428–e432. [Google Scholar]
30.
Cheshmehzangi A. Urban health and sustaining peace during and after the COVID-19 pandemic. J. Infect. Dis. Prev. Med. 2021, 9, 1000219. [Google Scholar]
TOP